Tapewire

Nasdaq · USD

DNTH

Dianthus Therapeutics, Inc. /DE/

Export transactions ↓
Tapewire entity
1813
SEC CIK
0001690585
Parsed reports
289

Last 12 months

Inside the activity.

0 purchase rows · 66 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202504
Dec 202501
Jan 202600
Feb 202600
Mar 2026021
Apr 202601
May 202601
Jun 202605
Jul 202603
Aug 2026022
Sep 202608
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 07, 2026 Filed Aug 7, 2026 22:30 UTC
Garcia MarinoDirector · CEO AND PRESIDENT
Exercise / conversionCommon Stock 126,000 $8.44 $1,063,440.00
Disclosure

SEC source: 0001669866-26-000010 · ownership.xml · nonDerivative · entry 2

Garcia Marino · CIK 0001669866 · Director · CEO AND PRESIDENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 231,292

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 07, 2026 Filed Aug 7, 2026 22:30 UTC
Garcia MarinoDirector · CEO AND PRESIDENT
Exercise / conversionCommon Stock 40,000 $8.44 $337,600.00
Disclosure

SEC source: 0001669866-26-000010 · ownership.xml · nonDerivative · entry 1

Garcia Marino · CIK 0001669866 · Director · CEO AND PRESIDENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 105,292

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 8, 2026.

Read SEC document
August 07, 2026 Filed Aug 11, 2026 21:08 UTC
Veness Adam MSVP, General Counsel and Sec.
Exercise / conversionStock Option (Right to Buy) · Derivative 3,833 $0.00 Strike: $17.88 $0.00
Disclosure

SEC source: 0001778623-26-000007 · ownership.xml · derivative · entry 6

Veness Adam M · CIK 0001778623 · SVP, General Counsel and Sec.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 76,167

Underlying: Common Stock · 3,833 shares

Expires 2034-01-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026.

F5 · derivative.exercise_date: The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after January 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Read SEC document
August 07, 2026 Filed Aug 11, 2026 21:08 UTC
Veness Adam MSVP, General Counsel and Sec.
SaleCommon Stock 616 $111.18 $68,486.88
Disclosure

SEC source: 0001778623-26-000007 · ownership.xml · nonDerivative · entry 3

Veness Adam M · CIK 0001778623 · SVP, General Counsel and Sec.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026.

F3 · price: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $111.08 to $111.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 07, 2026 Filed Aug 11, 2026 21:08 UTC
Veness Adam MSVP, General Counsel and Sec.
SaleCommon Stock 3,217 $110.61 $355,832.37
Disclosure

SEC source: 0001778623-26-000007 · ownership.xml · nonDerivative · entry 2

Veness Adam M · CIK 0001778623 · SVP, General Counsel and Sec.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 616

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026.

F2 · price: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $110.07 to $111.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 07, 2026 Filed Aug 11, 2026 21:08 UTC
Veness Adam MSVP, General Counsel and Sec.
Exercise / conversionCommon Stock 3,833 $17.88 $68,534.04
Disclosure

SEC source: 0001778623-26-000007 · ownership.xml · nonDerivative · entry 1

Veness Adam M · CIK 0001778623 · SVP, General Counsel and Sec.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,833

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026.

Read SEC document
July 09, 2026 Filed Jul 13, 2026 21:00 UTC
Savitz RyanEVP, CFO & CBO
Exercise / conversionStock Option (Right to Buy) · Derivative 31,249 $0.00 Strike: $21.77 $0.00
Disclosure

SEC source: 0001992324-26-000008 · ownership.xml · derivative · entry 5

Savitz Ryan · CIK 0001992324 · EVP, CFO & CBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 68,751

Underlying: Common Stock · 31,249 shares

Expires 2034-05-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025.

F5 · derivative.exercise_date: The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after May 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Read SEC document
July 09, 2026 Filed Jul 13, 2026 21:00 UTC
Savitz RyanEVP, CFO & CBO
SaleCommon Stock 5,566 $101.97 $567,565.02
Disclosure

SEC source: 0001992324-26-000008 · ownership.xml · nonDerivative · entry 4

Savitz Ryan · CIK 0001992324 · EVP, CFO & CBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025.

F4 · price: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $101.95 to $102.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
July 09, 2026 Filed Jul 13, 2026 21:00 UTC
Savitz RyanEVP, CFO & CBO
SaleCommon Stock 15,329 $101.24 $1,551,907.96
Disclosure

SEC source: 0001992324-26-000008 · ownership.xml · nonDerivative · entry 3

Savitz Ryan · CIK 0001992324 · EVP, CFO & CBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,566

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025.

F3 · price: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $100.78 to $101.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
July 09, 2026 Filed Jul 13, 2026 21:00 UTC
Savitz RyanEVP, CFO & CBO
SaleCommon Stock 10,354 $100.22 $1,037,677.88
Disclosure

SEC source: 0001992324-26-000008 · ownership.xml · nonDerivative · entry 2

Savitz Ryan · CIK 0001992324 · EVP, CFO & CBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,895

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025.

F2 · price: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $99.75 to $100.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
July 09, 2026 Filed Jul 13, 2026 21:00 UTC
Savitz RyanEVP, CFO & CBO
Exercise / conversionCommon Stock 31,249 $21.77 $680,290.73
Disclosure

SEC source: 0001992324-26-000008 · ownership.xml · nonDerivative · entry 1

Savitz Ryan · CIK 0001992324 · EVP, CFO & CBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 31,249

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025.

Read SEC document
June 17, 2026 Filed Jun 18, 2026 20:30 UTC
Veness Adam MSVP, General Counsel and Sec.
Exercise / conversionStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $17.88 $0.00
Disclosure

SEC source: 0001778623-26-000005 · ownership.xml · derivative · entry 4

Veness Adam M · CIK 0001778623 · SVP, General Counsel and Sec.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 30,000 shares

Expires 2034-01-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026.

F4 · derivative.exercise_date: The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after January 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Read SEC document
June 17, 2026 Filed Jun 18, 2026 20:30 UTC
Veness Adam MSVP, General Counsel and Sec.
SaleCommon Stock 13,229 $81.38 $1,076,576.02
Disclosure

SEC source: 0001778623-26-000005 · ownership.xml · nonDerivative · entry 3

Veness Adam M · CIK 0001778623 · SVP, General Counsel and Sec.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026.

F3 · price: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $81.00 to $81.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
June 17, 2026 Filed Jun 18, 2026 20:30 UTC
Veness Adam MSVP, General Counsel and Sec.
SaleCommon Stock 16,771 $80.34 $1,347,382.14
Disclosure

SEC source: 0001778623-26-000005 · ownership.xml · nonDerivative · entry 2

Veness Adam M · CIK 0001778623 · SVP, General Counsel and Sec.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 13,229

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026.

F2 · price: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $80.00 to $80.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
June 17, 2026 Filed Jun 18, 2026 20:30 UTC
Veness Adam MSVP, General Counsel and Sec.
Exercise / conversionCommon Stock 30,000 $17.88 $536,400.00
Disclosure

SEC source: 0001778623-26-000005 · ownership.xml · nonDerivative · entry 1

Veness Adam M · CIK 0001778623 · SVP, General Counsel and Sec.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 30,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 18, 2026.

Read SEC document
June 01, 2026 Filed Jun 2, 2026 23:00 UTC
Randhawa SimratEVP, Head of R&D
Exercise / conversionStock Option (Right to Buy) · Derivative 9,375 $0.00 Strike: $22.07 $0.00
Disclosure

SEC source: 0001992260-26-000006 · ownership.xml · derivative · entry 11

Randhawa Simrat · CIK 0001992260 · EVP, Head of R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 96,875

Underlying: Common Stock · 9,375 shares

Expires 2035-02-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2025.

F8 · derivative.exercise_date: The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after January 1, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Read SEC document
June 01, 2026 Filed Jun 2, 2026 23:00 UTC
Randhawa SimratEVP, Head of R&D
Exercise / conversionStock Option (Right to Buy) · Derivative 6,249 $0.00 Strike: $21.77 $0.00
Disclosure

SEC source: 0001992260-26-000006 · ownership.xml · derivative · entry 10

Randhawa Simrat · CIK 0001992260 · EVP, Head of R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 47,925

Underlying: Common Stock · 6,249 shares

Expires 2034-05-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2025.

F7 · derivative.exercise_date: The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after May 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Read SEC document
June 01, 2026 Filed Jun 2, 2026 23:00 UTC
Randhawa SimratEVP, Head of R&D
Exercise / conversionStock Option (Right to Buy) · Derivative 6,908 $0.00 Strike: $17.88 $0.00
Disclosure

SEC source: 0001992260-26-000006 · ownership.xml · derivative · entry 9

Randhawa Simrat · CIK 0001992260 · EVP, Head of R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 64,276

Underlying: Common Stock · 6,908 shares

Expires 2034-01-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2025.

F6 · derivative.exercise_date: The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after January 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Read SEC document
June 01, 2026 Filed Jun 2, 2026 23:00 UTC
Randhawa SimratEVP, Head of R&D
Exercise / conversionStock Option (Right to Buy) · Derivative 3,998 $0.00 Strike: $8.44 $0.00
Disclosure

SEC source: 0001992260-26-000006 · ownership.xml · derivative · entry 8

Randhawa Simrat · CIK 0001992260 · EVP, Head of R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,998 shares

Expires 2032-06-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2025.

F5 · derivative.exercise_date: The shares of common stock underlying this stock option award vested as to 25% of the shares on April 25, 2023, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Read SEC document
June 01, 2026 Filed Jun 2, 2026 23:00 UTC
Randhawa SimratEVP, Head of R&D
SaleCommon Stock 4,159 $91.37 $380,007.83
Disclosure

SEC source: 0001992260-26-000006 · ownership.xml · nonDerivative · entry 7

Randhawa Simrat · CIK 0001992260 · EVP, Head of R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,000

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2025.

F4 · price: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $91.17 to $91.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
June 01, 2026 Filed Jun 2, 2026 23:00 UTC
Randhawa SimratEVP, Head of R&D
SaleCommon Stock 16,943 $90.72 $1,537,068.96
Disclosure

SEC source: 0001992260-26-000006 · ownership.xml · nonDerivative · entry 6

Randhawa Simrat · CIK 0001992260 · EVP, Head of R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,159

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2025.

F3 · price: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $90.17 to $91.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
June 01, 2026 Filed Jun 2, 2026 23:00 UTC
Randhawa SimratEVP, Head of R&D
SaleCommon Stock 5,428 $89.72 $487,000.16
Disclosure

SEC source: 0001992260-26-000006 · ownership.xml · nonDerivative · entry 5

Randhawa Simrat · CIK 0001992260 · EVP, Head of R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,102

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2025.

F2 · price: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $89.17 to $90.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
June 01, 2026 Filed Jun 2, 2026 23:00 UTC
Randhawa SimratEVP, Head of R&D
Exercise / conversionCommon Stock 9,375 $22.07 $206,906.25
Disclosure

SEC source: 0001992260-26-000006 · ownership.xml · nonDerivative · entry 4

Randhawa Simrat · CIK 0001992260 · EVP, Head of R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 30,530

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2025.

Read SEC document
June 01, 2026 Filed Jun 2, 2026 23:00 UTC
Randhawa SimratEVP, Head of R&D
Exercise / conversionCommon Stock 6,249 $21.77 $136,040.73
Disclosure

SEC source: 0001992260-26-000006 · ownership.xml · nonDerivative · entry 3

Randhawa Simrat · CIK 0001992260 · EVP, Head of R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 21,155

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2025.

Read SEC document
June 01, 2026 Filed Jun 2, 2026 23:00 UTC
Randhawa SimratEVP, Head of R&D
Exercise / conversionCommon Stock 6,908 $17.88 $123,515.04
Disclosure

SEC source: 0001992260-26-000006 · ownership.xml · nonDerivative · entry 2

Randhawa Simrat · CIK 0001992260 · EVP, Head of R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,906

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2025.

Read SEC document
June 01, 2026 Filed Jun 2, 2026 23:00 UTC
Randhawa SimratEVP, Head of R&D
Exercise / conversionCommon Stock 3,998 $8.44 $33,743.12
Disclosure

SEC source: 0001992260-26-000006 · ownership.xml · nonDerivative · entry 1

Randhawa Simrat · CIK 0001992260 · EVP, Head of R&D

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,998

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on August 14, 2025.

Read SEC document
May 21, 2026 Filed May 22, 2026 20:30 UTC GrantStock Option (Right to Buy) · Derivative 6,090 $0.00 Strike: $89.63 $0.00
Disclosure

SEC source: 0001692444-26-000010 · ownership.xml · derivative · entry 1

Soteropoulos Paula · CIK 0001692444 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,090

Underlying: Common Stock · 6,090 shares

Expires 2036-05-21

F1 · derivative.exercise_date: The shares of common stock underlying this stock option award will vest in full on the date that is the earlier of (i) the first anniversary of the grant date or (ii) the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through the vesting date.

Read SEC document
May 21, 2026 Filed May 22, 2026 20:30 UTC
Read SimonDirector
GrantStock Option (Right to Buy) · Derivative 6,090 $0.00 Strike: $89.63 $0.00
Disclosure

SEC source: 0001688199-26-000002 · ownership.xml · derivative · entry 1

Read Simon · CIK 0001688199 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,090

Underlying: Common Stock · 6,090 shares

Expires 2036-05-21

F1 · derivative.exercise_date: The shares of common stock underlying this stock option award will vest in full on the date that is the earlier of (i) the first anniversary of the grant date or (ii) the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through the vesting date.

Read SEC document
May 21, 2026 Filed May 22, 2026 20:30 UTC GrantStock Option (Right to Buy) · Derivative 6,090 $0.00 Strike: $89.63 $0.00
Disclosure

SEC source: 0001639860-26-000005 · ownership.xml · derivative · entry 1

Romano Steven J. · CIK 0001639860 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,090

Underlying: Common Stock · 6,090 shares

Expires 2036-05-21

F1 · derivative.exercise_date: The shares of common stock underlying this stock option award will vest in full on the date that is the earlier of (i) the first anniversary of the grant date or (ii) the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through the vesting date.

Read SEC document
May 21, 2026 Filed May 22, 2026 20:30 UTC GrantStock Option (Right to Buy) · Derivative 6,090 $0.00 Strike: $89.63 $0.00
Disclosure

SEC source: 0001779934-26-000002 · ownership.xml · derivative · entry 1

McGeorge Anne · CIK 0001779934 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,090

Underlying: Common Stock · 6,090 shares

Expires 2036-05-21

F1 · derivative.exercise_date: The shares of common stock underlying this stock option award will vest in full on the date that is the earlier of (i) the first anniversary of the grant date or (ii) the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through the vesting date.

Read SEC document
May 21, 2026 Filed May 22, 2026 20:30 UTC GrantStock Option (Right to Buy) · Derivative 6,090 $0.00 Strike: $89.63 $0.00
Disclosure

SEC source: 0001542650-26-000002 · ownership.xml · derivative · entry 1

Lawton Alison Frances · CIK 0001542650 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,090

Underlying: Common Stock · 6,090 shares

Expires 2036-05-21

F1 · derivative.exercise_date: The shares of common stock underlying this stock option award will vest in full on the date that is the earlier of (i) the first anniversary of the grant date or (ii) the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through the vesting date.

Read SEC document
May 21, 2026 Filed May 22, 2026 20:30 UTC
KANGO SUJAYDirector
GrantStock Option (Right to Buy) · Derivative 6,090 $0.00 Strike: $89.63 $0.00
Disclosure

SEC source: 0001336503-26-000002 · ownership.xml · derivative · entry 1

KANGO SUJAY · CIK 0001336503 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,090

Underlying: Common Stock · 6,090 shares

Expires 2036-05-21

F1 · derivative.exercise_date: The shares of common stock underlying this stock option award will vest in full on the date that is the earlier of (i) the first anniversary of the grant date or (ii) the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through the vesting date.

Read SEC document
May 21, 2026 Filed May 22, 2026 20:30 UTC GrantStock Option (Right to Buy) · Derivative 6,090 $0.00 Strike: $89.63 $0.00
Disclosure

SEC source: 0001730615-26-000003 · ownership.xml · derivative · entry 1

Violin Jonathan · CIK 0001730615 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,090

Underlying: Common Stock · 6,090 shares

Expires 2036-05-21

F1 · derivative.exercise_date: The shares of common stock underlying this stock option award will vest in full on the date that is the earlier of (i) the first anniversary of the grant date or (ii) the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through the vesting date.

Read SEC document
May 08, 2026 Filed May 11, 2026 21:00 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 599 $0.00 Strike: $8.44 $0.00
Disclosure

SEC source: 0001692444-26-000008 · ownership.xml · derivative · entry 3

Soteropoulos Paula · CIK 0001692444 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 599 shares

Expires 2032-06-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 23, 2025.

F2 · derivative.exercise_date: The shares of common stock underlying this stock option award vested as to 25% of the shares on April 6, 2023, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Read SEC document
May 08, 2026 Filed May 11, 2026 21:00 UTC SaleCommon Stock 599 $85.47 $51,196.53
Disclosure

SEC source: 0001692444-26-000008 · ownership.xml · nonDerivative · entry 2

Soteropoulos Paula · CIK 0001692444 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 23, 2025.

Read SEC document
May 08, 2026 Filed May 11, 2026 21:00 UTC Exercise / conversionCommon Stock 599 $8.44 $5,055.56
Disclosure

SEC source: 0001692444-26-000008 · ownership.xml · nonDerivative · entry 1

Soteropoulos Paula · CIK 0001692444 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 599

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 23, 2025.

Read SEC document
April 09, 2026 Filed Apr 10, 2026 20:52 UTC
Savitz RyanEVP, CFO & CBO
Exercise / conversionStock Option (Right to Buy) · Derivative 8,224 $0.00 Strike: $17.88 $0.00
Disclosure

SEC source: 0001992324-26-000006 · ownership.xml · derivative · entry 3

Savitz Ryan · CIK 0001992324 · EVP, CFO & CBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 71,776

Underlying: Common Stock · 8,224 shares

Expires 2034-01-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025.

F3 · derivative.exercise_date: The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after January 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Read SEC document
April 09, 2026 Filed Apr 10, 2026 20:52 UTC
Savitz RyanEVP, CFO & CBO
SaleCommon Stock 8,224 $89.84 $738,844.16
Disclosure

SEC source: 0001992324-26-000006 · ownership.xml · nonDerivative · entry 2

Savitz Ryan · CIK 0001992324 · EVP, CFO & CBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025.

F2 · price: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $89.75 to $89.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
April 09, 2026 Filed Apr 10, 2026 20:52 UTC
Savitz RyanEVP, CFO & CBO
Exercise / conversionCommon Stock 8,224 $17.88 $147,045.12
Disclosure

SEC source: 0001992324-26-000006 · ownership.xml · nonDerivative · entry 1

Savitz Ryan · CIK 0001992324 · EVP, CFO & CBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,224

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025.

Read SEC document
March 31, 2026 Filed Apr 1, 2026 21:26 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 599 $0.00 Strike: $8.44 $0.00
Disclosure

SEC source: 0001692444-26-000006 · ownership.xml · derivative · entry 3

Soteropoulos Paula · CIK 0001692444 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 599

Underlying: Common Stock · 599 shares

Expires 2032-06-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025.

F2 · derivative.exercise_date: The shares of common stock underlying this stock option award vested as to 25% of the shares on April 6, 2023, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Read SEC document
March 31, 2026 Filed Apr 1, 2026 21:26 UTC SaleCommon Stock 599 $80.11 $47,985.89
Disclosure

SEC source: 0001692444-26-000006 · ownership.xml · nonDerivative · entry 2

Soteropoulos Paula · CIK 0001692444 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025.

Read SEC document
March 31, 2026 Filed Apr 1, 2026 21:26 UTC Exercise / conversionCommon Stock 599 $8.44 $5,055.56
Disclosure

SEC source: 0001692444-26-000006 · ownership.xml · nonDerivative · entry 1

Soteropoulos Paula · CIK 0001692444 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 599

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025.

Read SEC document
March 31, 2026 Filed Apr 1, 2026 21:26 UTC
Savitz RyanEVP, CFO & CBO
Exercise / conversionStock Option (Right to Buy) · Derivative 40,000 $0.00 Strike: $17.88 $0.00
Disclosure

SEC source: 0001992324-26-000004 · ownership.xml · derivative · entry 12

Savitz Ryan · CIK 0001992324 · EVP, CFO & CBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 40,000 shares

Expires 2034-01-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025.

F11 · derivative.exercise_date: The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after January 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Read SEC document
March 31, 2026 Filed Apr 1, 2026 21:26 UTC
Savitz RyanEVP, CFO & CBO
Exercise / conversionStock Option (Right to Buy) · Derivative 74,367 $0.00 Strike: $8.44 $0.00
Disclosure

SEC source: 0001992324-26-000004 · ownership.xml · derivative · entry 11

Savitz Ryan · CIK 0001992324 · EVP, CFO & CBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,399

Underlying: Common Stock · 74,367 shares

Expires 2032-06-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025.

F10 · derivative.exercise_date: The shares of common stock underlying this stock option award vested as to 25% of the shares on June 2, 2023, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date.

Read SEC document
March 31, 2026 Filed Apr 1, 2026 21:26 UTC
Savitz RyanEVP, CFO & CBO
SaleCommon Stock 7,232 $85.54 $618,625.28
Disclosure

SEC source: 0001992324-26-000004 · ownership.xml · nonDerivative · entry 10

Savitz Ryan · CIK 0001992324 · EVP, CFO & CBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025.

F9 · price: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.25 to $85.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 31, 2026 Filed Apr 1, 2026 21:26 UTC
Savitz RyanEVP, CFO & CBO
SaleCommon Stock 19,469 $84.57 $1,646,493.33
Disclosure

SEC source: 0001992324-26-000004 · ownership.xml · nonDerivative · entry 9

Savitz Ryan · CIK 0001992324 · EVP, CFO & CBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,232

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025.

F8 · price: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $84.25 to $85.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 31, 2026 Filed Apr 1, 2026 21:26 UTC
Savitz RyanEVP, CFO & CBO
SaleCommon Stock 59,800 $83.90 $5,017,220.00
Disclosure

SEC source: 0001992324-26-000004 · ownership.xml · nonDerivative · entry 8

Savitz Ryan · CIK 0001992324 · EVP, CFO & CBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 26,701

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025.

F7 · price: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $83.25 to $84.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 31, 2026 Filed Apr 1, 2026 21:26 UTC
Savitz RyanEVP, CFO & CBO
SaleCommon Stock 2,366 $82.84 $195,999.44
Disclosure

SEC source: 0001992324-26-000004 · ownership.xml · nonDerivative · entry 7

Savitz Ryan · CIK 0001992324 · EVP, CFO & CBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 86,501

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025.

F6 · price: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $82.25 to $83.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 31, 2026 Filed Apr 1, 2026 21:26 UTC
Savitz RyanEVP, CFO & CBO
SaleCommon Stock 800 $81.36 $65,088.00
Disclosure

SEC source: 0001992324-26-000004 · ownership.xml · nonDerivative · entry 6

Savitz Ryan · CIK 0001992324 · EVP, CFO & CBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 88,867

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025.

F5 · price: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $81.15 to $81.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 31, 2026 Filed Apr 1, 2026 21:26 UTC
Savitz RyanEVP, CFO & CBO
SaleCommon Stock 1,485 $80.25 $119,171.25
Disclosure

SEC source: 0001992324-26-000004 · ownership.xml · nonDerivative · entry 5

Savitz Ryan · CIK 0001992324 · EVP, CFO & CBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 89,667

F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025.

F4 · price: The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $80.11 to $81.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.